Author:
Burish Mark J,Aysenne Aimee,Singh Vineeta
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference22 articles.
1. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CRM: Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007, 109: 1870-1877. 10.1182/blood-2006-06-029850.
2. Yee TT, Taher A, Pasi KJ, Lee CA: A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol. 2000, 22: 275-278. 10.1046/j.1365-2257.2000.00316.x.
3. Philipp C: The aging patient with hemophilia: complications, comorbidities, and management issues. Hematology Am Soc Hematol Educ Program. 2010, 2010: 191-196. 10.1182/asheducation-2010.1.191.
4. Witmer C, Presley R, Kulkarni R, Soucie JM, Manno CS, Raffini L: Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol. 2011, 152: 211-216. 10.1111/j.1365-2141.2010.08469.x.
5. Nakar C, Cooper DL, DiMichele D: Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008). Haemophilia. 2010, 16: 625-631.